Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H7INO3.Na |
Molecular Weight | 323.0521 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[O-]C(=O)CNC(=O)C1=CC=CC=C1[123I]
InChI
InChIKey=XYITYKDGJLHYPW-TWDNZPFZSA-M
InChI=1S/C9H8INO3.Na/c10-7-4-2-1-3-6(7)9(14)11-5-8(12)13;/h1-4H,5H2,(H,11,14)(H,12,13);/q;+1/p-1/i10-4;
Molecular Formula | C9H7INO3 |
Molecular Weight | 300.0624 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/10987332Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/6485965 | https://www.ncbi.nlm.nih.gov/pubmed/6492475 | https://www.ncbi.nlm.nih.gov/pubmed/3680968 | https://www.ncbi.nlm.nih.gov/pubmed/2208882 | https://www.ncbi.nlm.nih.gov/pubmed/8767955 | https://www.ncbi.nlm.nih.gov/pubmed/8827809 | https://www.ncbi.nlm.nih.gov/pubmed/6677098
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10987332
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/6485965 | https://www.ncbi.nlm.nih.gov/pubmed/6492475 | https://www.ncbi.nlm.nih.gov/pubmed/3680968 | https://www.ncbi.nlm.nih.gov/pubmed/2208882 | https://www.ncbi.nlm.nih.gov/pubmed/8767955 | https://www.ncbi.nlm.nih.gov/pubmed/8827809 | https://www.ncbi.nlm.nih.gov/pubmed/6677098
I-123 radiolabeled ortho-iodohippurate is commonly employed for evaluating effective renal plasma flow (ERPF) by means of either in vivo scintigraphy and/or plasma clearance curves. It has been used to evaluate renal functioning in patients with obstructive uropathy, vesicorenal reflux, hypertensiion due to renal artery stenosis.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6485965 https://www.ncbi.nlm.nih.gov/pubmed/6492475 https://www.ncbi.nlm.nih.gov/pubmed/3680968 https://www.ncbi.nlm.nih.gov/pubmed/2208882 https://www.ncbi.nlm.nih.gov/pubmed/8767955 https://www.ncbi.nlm.nih.gov/pubmed/8827809 https://www.ncbi.nlm.nih.gov/pubmed/6677098 |
Diagnostic | IODOHIPPURATE SODIUM I-123 Approved UseUnknown Launch Date1984 |
PubMed
Title | Date | PubMed |
---|---|---|
[Age and sex dependence of tubular kidney clearance in childhood]. | 1984 Oct 25 |
|
A simplified method for the routine determination of effective renal plasma flow. | 1986 Nov |
|
Diminished response to furosemide in I-123 Hippuran renal studies of renovascular hypertension caused by unilateral renal artery stenosis. | 1990 Sep |
|
Comparison of scintigraphic renal differentials using radiolabeled orthoiodohippurate and glucoheptonate. | 1991 Jun |
|
[Mean renal transit time of I-123 orthoiodohippurate in normotensive and hypertensive subjects]. | 1996 Jan-Feb |
|
Measurement of effective renal plasma flow (ERPF) with 123I-orthoiodohippurate (I-123-OIH). | 1996 May-Jun |
|
Modification of measurement of effective renal plasma flow from blood pool clearance curve of I-123-orthoiodohippurate using single blood sampling. | 1998 Jul-Aug |
|
Evaluation of effective renal plasma flow with I-127 ortho-iodohippurate and I-123 ortho-iodohippurate in rabbits. | 2000 Sep |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6677098
After 1 mCi of I-123- orthoiodohippurate was given intravenously, serial renal scintigrams were obtained for 25 minutes and regional renogram curves were derived from the whole kidney, the cortical and pelvic areas.
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:21:06 GMT 2023
by
admin
on
Fri Dec 15 15:21:06 GMT 2023
|
Record UNII |
4NW20GFQ7H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2124
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
||
|
WHO-VATC |
QV09CX01
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000084951
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY | |||
|
4NW20GFQ7H
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY | |||
|
m6347
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID60204805
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY | |||
|
91551
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY | RxNorm | ||
|
56254-07-0
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY | |||
|
C76279
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL1681
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY | |||
|
23667636
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY | |||
|
Iodohippurate Sodium I 123
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY | |||
|
SUB04458MIG
Created by
admin on Fri Dec 15 15:21:07 GMT 2023 , Edited by admin on Fri Dec 15 15:21:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |